Cell attachment and motility on materials modified by surface-active RGD-containing peptides.
Telios Pharmaceuticals, Inc., San Diego, California 92121.
J
J
Glass
J
J
Blevitt
K
K
Dickerson
M
M
Pierschbacher
W S
WS
Craig
D000199:Actins / Q000032:analysis; D000595:Amino Acid Sequence; D001672:Biocompatible Materials; D001859:Bone Neoplasms / Q000473:pathology; D002448:Cell Adhesion / Q000187:drug effects*; D002465:Cell Movement / Q000187:drug effects*; D002478:Cells, Cultured; D005347:Fibroblasts / Q000166:cytology; D006801:Humans; D008969:Molecular Sequence Data; D009842:Oligopeptides / Q000494:pharmacology*; D012516:Osteosarcoma / Q000473:pathology; D010455:Peptides / Q000138:chemical synthesis / Q000494:pharmacology*; D011093:Polyethylene Terephthalates; D012867:Skin; D013499:Surface Properties; D014407:Tumor Cells, Cultured
D000199:Actins; D001672:Biocompatible Materials; D009842:Oligopeptides; D010455:Peptides; D011093:Polyethylene Terephthalates; C047981:arginyl-glycyl-aspartic acid